Proactive Acne Solution


 Proactive Acne Solution Treatment For Acne
Lyn Ross Launches The Specialized Sensitive Skin Laser Program.

Lyn Ross of Institut' DERMed in Atlanta launches a new Specialized Sensitive Skin Laser Program to minimize discomfort and maximize the benefits when treating hyper-sensitive skin.

Atlanta, GA (PRWEB) November 4, 2007 -- Lyn Ross of Institut' DERMed in Atlanta launches a new Specialized Sensitive Skin Laser Program to minimize discomfort and maximize the benefits when treating hyper-sensitive skin.

The Specialized Sensitive Skin Laser Program at Institut' DERMed in Atlanta combines superior technology with superior technique and superior product. Besides the use of a numbing cream, discussed on a client by client basis in the pre-treatment consultation, the technician also prepares the skin with the Institut' DERMed Sensitive Skin Cleanser, a foaming facial wash containing licorice root extract and laurel berries known for soothing and calming hyper-sensitive skin and the Institut' DERMed Sensitive Skin Toner, a specially formulated anti-inflammatory containing green tea extract and willow herb.


Spa Luce at Renaissance Hollywood Hotel Announces Product Lines for Grand Opening in March, 2008

The Renaissance Hollywood Hotel is pleased to announce the three exciting product lines that will be available when the new Spa Luce opens this spring. Among the industry's elite, Sonya Dakar Skincare, the Somme Institute, and Red Flower all represent the spa's complete commitment to all-around natural beauty. .


Isolagen Initiates Phase III Clinical Program To Investigate Isolagen Therapy(TM) For The Treatment Of Acne Scars

Isolagen(TM), Inc. (Amex: ILE) announces the initiation of a Phase III clinical program to investigate Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. Isolagen also has a pivotal Phase III clinical program underway to evaluate the Isolagen Therapy in treating nasolabial folds, or wrinkles.

"Millions of people in the U.S. suffer from acne which often scars, a condition that can be very distressing and difficult to treat as there are few options currently available," said Nicholas L. Teti, Jr., Chairman and Chief Executive Officer of Isolagen. "We are pleased to be initiating this important clinical development program which we believe will address this largely unmet medical need."

Two randomized, double-blind, placebo-controlled trials will evaluate the safety and efficacy of Isolagen Therapy in patients with moderate to severe acne scarring on both sides of the face.


 
Link to us - Contact us